Switzerland: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Switzerland

After two years of growth, the Swiss prophylactic medicaments containing insulin market decreased by -34.8% to $X in 2022. In general, consumption continues to indicate a drastic downturn. Prophylactic medicaments containing insulin consumption peaked at $X in 2015; however, from 2016 to 2022, consumption stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Switzerland

Prophylactic medicaments containing insulin exports from Switzerland soared to X kg in 2022, with an increase of 43% against the previous year. Over the period under review, exports, however, recorded a abrupt descent. The growth pace was the most rapid in 2015 with an increase of 4,700%. Over the period under review, the exports attained the maximum at X kg in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2022. In general, exports, however, showed a abrupt slump. The most prominent rate of growth was recorded in 2015 when exports increased by 19,318% against the previous year. Over the period under review, the exports attained the maximum at $X in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

Exports by Country

Germany (X kg) was the main destination for prophylactic medicaments containing insulin exports from Switzerland, with a 63% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Germany exceeded the volume sent to the second major destination, Japan (X kg), threefold. The third position in this ranking was taken by Holy See (X kg), with a 6.7% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to Germany totaled -15.6%. Exports to the other major destinations recorded the following average annual rates of exports growth: Japan (0.0% per year) and Holy See (+14.9% per year).

In value terms, Germany ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Switzerland, comprising 67% of total exports. The second position in the ranking was taken by Holy See ($X), with a 15% share of total exports. It was followed by Kuwait, with a 9.8% share.

From 2012 to 2022, the average annual rate of growth in terms of value to Germany totaled -16.3%. Exports to the other major destinations recorded the following average annual rates of exports growth: Holy See (+44.3% per year) and Kuwait (0.0% per year).

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, with an increase of 17% against the previous year. Overall, the export price, however, continues to indicate a noticeable descent. The most prominent rate of growth was recorded in 2015 an increase of 305% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2016 to 2022, the average export prices remained at a somewhat lower figure.

There were significant differences in the average prices for the major export markets. In 2022, amid the top suppliers, the country with the highest price was Kuwait ($X per ton), while the average price for exports to San Marino ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Holy See (+25.6%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Switzerland

In 2022, purchases abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -42.7% to X tons for the first time since 2019, thus ending a two-year rising trend. In general, imports continue to indicate a deep setback. The most prominent rate of growth was recorded in 2020 with an increase of 43% against the previous year. Over the period under review, imports reached the maximum at X tons in 2015; however, from 2016 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports dropped notably to $X in 2022. Overall, imports recorded a deep contraction. The pace of growth appeared the most rapid in 2015 when imports increased by 25%. As a result, imports reached the peak of $X. From 2016 to 2022, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2022, France (X tons) constituted the largest prophylactic medicaments containing insulin supplier to Switzerland, with a 61% share of total imports. Moreover, prophylactic medicaments containing insulin imports from France exceeded the figures recorded by the second-largest supplier, Italy (X tons), threefold. Germany (X tons) ranked third in terms of total imports with a 5.3% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from France totaled +21.5%. The remaining supplying countries recorded the following average annual rates of imports growth: Italy (+0.5% per year) and Germany (-22.1% per year).

In value terms, France ($X), Germany ($X) and Italy ($X) were the largest prophylactic medicaments containing insulin suppliers to Switzerland, together accounting for 93% of total imports.

Among the main suppliers, France, with a CAGR of +29.0%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced mixed trend patterns.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, picking up by 17% against the previous year. Over the last decade, it increased at an average annual rate of +2.1%. The growth pace was the most rapid in 2018 when the average import price increased by 25%. The import price peaked in 2022 and is likely to see steady growth in years to come.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Germany ($X per ton), while the price for Italy ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Germany (+20.2%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :